ARTLVSGTBP• 12 Months (Normalized)
ARTL vs GTBP (Artelo Biosciences Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1071.21%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1071.21 pts
GTBP outperforming by 1071.21 percentage points
ARTLGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ARTL Price | ARTL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $6.88 | +1071.21% | - | |
| Sep 28, 2026 | $- | $6.80 | +1058.43% | - | |
| Sep 25, 2026 | $4.54 | -96.34% | $6.89 | +1073.76% | -1170.10% |
| Sep 24, 2026 | $5.17 | -95.83% | $6.83 | +1063.54% | -1159.37% |
| Sep 23, 2026 | $7.31 | -94.10% | $7.10 | +1109.54% | -1203.64% |
| Sep 22, 2026 | $4.15 | -96.65% | $- | - | |
| Sep 21, 2026 | $4.10 | -96.69% | $7.18 | +1123.17% | -1219.86% |
| Sep 18, 2026 | $3.94 | -96.82% | $7.16 | +1119.76% | -1216.58% |
| Sep 17, 2026 | $3.97 | -96.80% | $7.49 | +1175.98% | -1272.78% |
| Sep 16, 2026 | $3.75 | -96.97% | $7.81 | +1230.49% | -1327.46% |
| Sep 15, 2026 | $5.34 | -95.69% | $9.00 | +1433.22% | -1528.91% |
| Sep 14, 2026 | $4.87 | -96.07% | $11.63 | +1881.26% | -1977.33% |
| Sep 11, 2026 | $5.43 | -95.62% | $8.61 | +1366.78% | -1462.40% |
| Sep 10, 2026 | $5.63 | -95.46% | $6.18 | +952.81% | -1048.27% |
| Sep 09, 2026 | $5.98 | -95.17% | $5.98 | +918.74% | -1013.91% |
Page 1 of 17